Recent Advances in Lipid Nanoparticle-Mediated Respiratory and Gastrointestinal Mucosal Delivery of Nucleic Acids
Open Access
- 31 July 2026
- journal article
- review article
- Published by MDPI AG in Bioengineering
- Vol. 13 (8) , 884
Abstract
The clinical translation of nucleic acids is severely hindered by multiple delivery barriers, such as enzymatic degradation, poor cellular uptake, endosomal entrapment, and rapid systemic clearance. Despite the remarkable therapeutic potential of these agents, conventional delivery systems often fail to address these challenges. Lipid nanoparticles (LNPs) have emerged as a versatile platform to overcome these obstacles, offering tunable physicochemical properties, high encapsulation efficiency, and pH-responsive endosomal escape. This review summarizes recent advances in LNP-based respiratory and gastrointestinal mucosal delivery of nucleic acids, with emphasis on formulation strategies for overcoming mucus and epithelial barriers. To overcome mucosal barriers, LNP studies have shown that keeping particle size below the local mucus mesh size (~100 nm), tuning surface charge toward near-neutrality via pH-responsive ionizable lipids, and maintaining a neutral, deformable, moderately PEGylated surface during the mucin transport stage can increase transmucosal diffusivity several-fold over conventional cationic LNPs. We further discuss current limitations and propose future directions, emphasizing the need for the integration of the pathological and physiological characteristics of specific mucosa with artificial intelligence (AI) platforms to develop intelligent and personalized delivery platforms with “spatiotemporal adaptive” capabilities.Keywords
Funding Information
- National Natural Science Foundation of China (2024YFA1210100)
- Science and Technology Department of Sichuan Province (2026NSFSC0564)
- National Natural Science Foundation of China (82304395)
- West China Hospital, Sichuan University (HXQMX0110)
- Sichuan Medical Association (2022TG01)
This publication has 122 references indexed in Scilit:
- N‐Acetylcysteine–Mediated Surface Remodeling of Inhaled mRNA Lipid Nanoparticles Enables Coordinated Mucosal and Systemic Antitumor ImmunityAdvanced Materials, 2026
- Lipid nanoparticle–based mRNA platforms for mucosal HIV vaccines: formulation advances, immune mechanisms, and translational pathwaysArchives of Microbiology, 2025
- Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA DeliveryAdvanced Science, 2025
- pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer ImmunotherapyAdvanced Materials, 2024
- A perspective of lipid nanoparticles for RNA deliveryExploration, 2024
- Exploring Mechanisms of Lipid Nanoparticle‐Mucus Interactions in Healthy and Cystic Fibrosis ConditionsAdvanced Healthcare Materials, 2024
- Modulation of the Crosstalk between Schwann Cells and Macrophages for Nerve Regeneration: A Therapeutic Strategy Based on a Multifunctional Tetrahedral Framework Nucleic Acids SystemAdvanced Materials, 2022
- Nanoparticles Containing Oxidized Cholesterol Deliver mRNA to the Liver Microenvironment at Clinically Relevant DosesAdvanced Materials, 2019
- Liposomes actively recognizing the glucose transporter GLUT1 and integrin αvβ3 for dual‐targeting of gliomaArchiv der Pharmazie, 2019
- Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular UptakeAdvanced Materials, 2014